VIDEX (Bristol-Myers Squibb Company)


Welcome to the PulseAid listing for the VIDEX drug offered from Bristol-Myers Squibb Company. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Bristol-Myers Squibb Company
NON-PROPRIETARY NAME: didanosine
SUBSTANCE NAME: DIDANOSINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1991-10-09
END MARKETING DATE: 0000-00-00


VIDEX HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVIDEX from Bristol-Myers Squibb Company
LABELER NAME: Bristol-Myers Squibb Company
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 1991-10-09
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0087-6632_a615c855-1dca-4aba-88a9-5a7be7e5ad5a
PRODUCT NDC: 0087-6632
APPLICATION NUMBER: NDA020156

Other DIDANOSINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Aurobindo Pharma LimitedDidanosine
Bristol-Myers Squibb CompanyVIDEX
Physicians Total Care, Inc.Didanosine
State of Florida DOH Central PharmacyDidanosine
Teva Pharmaceuticals USA, Inc.Didanosine